Suppr超能文献

人类免疫缺陷病毒感染成人中的消失性胆管综合征:两例报告。

Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

机构信息

Section of Infectious Diseases, Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27109-7205, USA.

出版信息

World J Gastroenterol. 2013 Jan 7;19(1):115-21. doi: 10.3748/wjg.v19.i1.115.

Abstract

Vanishing bile duct syndrome (VBDS) is a group of rare disorders characterized by ductopenia, the progressive destruction and disappearance of intrahepatic bile ducts leading to cholestasis. Described in association with medications, autoimmune disorders, cancer, transplantation, and infections, the specific mechanisms of disease are not known. To date, only 4 cases of VBDS have been reported in human immunodeficiency virus (HIV) infected patients. We report 2 additional cases of HIV-associated VBDS and review the features common to the HIV-associated cases. Presentation includes hyperbilirubinemia, normal liver imaging, and negative viral and autoimmune hepatitis studies. In HIV-infected subjects, VBDS occurred at a range of CD4+ T-cell counts, in some cases following initiation or change in antiretroviral therapy. Lymphoma was associated with two cases; nevirapine, antibiotics, and viral co-infection were suggested as etiologies in the other cases. In HIV-positive patients with progressive cholestasis, early identification of VBDS and referral for transplantation may improve outcomes.

摘要

进行性肝内胆汁淤积症(VBDS)是一组罕见疾病,其特征为胆管减少,即肝内胆管进行性破坏和消失,导致胆汁淤积。VBDS 与药物、自身免疫性疾病、癌症、移植和感染有关,但其具体发病机制尚不清楚。迄今为止,仅在人类免疫缺陷病毒(HIV)感染患者中报告了 4 例 VBDS。我们报告了另外 2 例 HIV 相关性 VBDS,并回顾了 HIV 相关性病例的共同特征。临床表现包括高胆红素血症、肝脏影像学正常以及病毒和自身免疫性肝炎检查均为阴性。在 HIV 感染者中,VBDS 发生在 CD4+ T 细胞计数的不同范围,在某些情况下,是在开始或改变抗逆转录病毒治疗后发生。有两例与淋巴瘤有关;在其他病例中,奈韦拉平、抗生素和病毒合并感染被认为是病因。在进行性胆汁淤积的 HIV 阳性患者中,早期识别 VBDS 并进行移植可能会改善预后。

相似文献

1
Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.
World J Gastroenterol. 2013 Jan 7;19(1):115-21. doi: 10.3748/wjg.v19.i1.115.
2
Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
World J Gastroenterol. 2017 Jan 14;23(2):366-372. doi: 10.3748/wjg.v23.i2.366.
3
Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
World J Gastroenterol. 2010 Jul 14;16(26):3335-8. doi: 10.3748/wjg.v16.i26.3335.
4
Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
Saudi J Gastroenterol. 2013 Nov-Dec;19(6):286-9. doi: 10.4103/1319-3767.121037.
5
Meropenem-induced vanishing bile duct syndrome.
Pharmacotherapy. 2010 Sep;30(9):953. doi: 10.1592/phco.30.9.953.
6
A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
Yonsei Med J. 2020 Dec;61(12):1060-1063. doi: 10.3349/ymj.2020.61.12.1060.
9
Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
J Clin Ultrasound. 2022 Nov;50(9):1368-1372. doi: 10.1002/jcu.23350. Epub 2022 Sep 23.
10
Vanishing Bile Duct Syndrome: A Differential Diagnosis for Painless Jaundice.
Cureus. 2024 Sep 5;16(9):e68724. doi: 10.7759/cureus.68724. eCollection 2024 Sep.

引用本文的文献

1
Fatal vanishing bile duct syndrome after cord blood transplantation mimicking HBV reactivation.
Clin J Gastroenterol. 2025 Aug;18(4):700-705. doi: 10.1007/s12328-025-02142-x. Epub 2025 Jun 10.
2
Case Report: Vanishing bile duct syndrome in Hodgkin's lymphoma: a case highlighting jaundice and lymphadenopathy as early clues.
Front Immunol. 2025 May 21;16:1561110. doi: 10.3389/fimmu.2025.1561110. eCollection 2025.
3
A case of successful treatment with antiretroviral therapy for HIV in a patient with marked liver dysfunction.
Heliyon. 2022 Nov 14;8(11):e11550. doi: 10.1016/j.heliyon.2022.e11550. eCollection 2022 Nov.
4
NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved.
Cells. 2021 Jul 4;10(7):1687. doi: 10.3390/cells10071687.
5
A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.
NPJ Breast Cancer. 2019 Jun 14;5:17. doi: 10.1038/s41523-019-0112-z. eCollection 2019.
6
Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: An ultrastructural perspective.
Ultrastruct Pathol. 2017 Mar-Apr;41(2):186-195. doi: 10.1080/01913123.2017.1282066. Epub 2017 Feb 28.

本文引用的文献

3
Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.
World J Gastroenterol. 2010 Jul 14;16(26):3335-8. doi: 10.3748/wjg.v16.i26.3335.
4
Valproic acid-associated vanishing bile duct syndrome.
J Child Neurol. 2010 Jul;25(7):909-11. doi: 10.1177/0883073809343474. Epub 2010 Apr 13.
5
Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.
Basic Clin Pharmacol Toxicol. 2010 Jan;106(1):62-5. doi: 10.1111/j.1742-7843.2009.00474.x. Epub 2009 Nov 9.
7
Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.
J Pediatr Hematol Oncol. 2008 Dec;30(12):976-80. doi: 10.1097/MPH.0b013e31818b37c4.
8
A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder.
J Paediatr Child Health. 2008 Apr;44(4):234-6. doi: 10.1111/j.1440-1754.2008.01291.x.
10
Vanishing bile duct syndrome.
Clin Liver Dis. 2008 Feb;12(1):203-17, x. doi: 10.1016/j.cld.2007.11.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验